Who we are
Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases.
At a glance
Our company by the numbers
50,129,284
Patients with neurodegenerative diseases
42
Employees living and working across the world
58%
Improvement in memory functions for clinical trial patients
2016
Year we were officially founded
Meet the team
You?
Zach Malchano
President
Brent Vaughan
Chief Executive Officer
Tom Megerian
Chief Medical Officer
Mihály Hajós
Chief Scientific Officer
Everett Crosland
Chief Commercial Officer
Divya Cohen
Vice President, Product
Martin Williams
Vice President, Business Development
Sean Gregory
Vice President, Health Economics & Market Access
Jennifer Newberger
Vice President, Regulatory & Compliance
Kim Kwan
Vice President, Research & Development
Kimberly Ha
Vice President, PR & Investor Relations
The Founders
Ed Boyden
Founder
Li-Huei Tsai
Founder
Our Advisory Board has decades of experience
Allan Levey, MD, PhD
Lead Clinical Advisor, Emory University
Director, Emory Brain Health Center, Emory Alzheimer's Disease Research Center; Director, Emory Brain Health Personalized Medicine Institute
Suzanne Craft, PhD
Clinical Advisor, Potential Investigator, Wake Forest University
Professor, Gerontology, Geriatric Medicine, Internal Medicine, Wake Forest University; Director, Wake Forest Alzheimer's Disease Research Center
Douglas Galasko, MD
Clinical Advisor, UC San Diego
Associate Director, Shiley-Marcos ADRC Clinical Core; Professor in Residence, Neurosciences
Paul Solomon, PhD
Investigator, Clinical Advisor, Boston Center for Memory
Founder, Clinical Director, Boston Center for Memory; Investigator, Boston University Alzheimer's Disease Center, Boston, University School of Medicine
Li-Huei Tsai, PhD
Founder, Advisor, MIT
Picower Professor of Neuroscience; Director, The Picower Institute for Learning and Memory; Co-Director, Alana Down Syndrome Center; Professor, Department of Brain aand Cognitive Sciences; Senior Associate Member, Broad Institute
Ed Boyden, PhD
Founder, Advisor, MIT
Y. Eva Tan Professor, Neurotechnology, Howard Hughes Medical Institute, McGovern Institute; Professor, Departments of Brain and Cognitive Sciences, Media Arts and Sciences, and Biological Engineering; Leader, Synthetic Neurobiology Group
Recognized and proud
Latest news and updates
Stay up to date
Mar 14, 2022
Ushering in a New Class of Disease-Modifying DTx
Mar 11, 2022
Cognito Therapeutics, Aetion to partner on AI model that identifies AD patients
Mar 7, 2022
Fierce Medtech's 2021 Fierce 15
Jan 27, 2022